113 related articles for article (PubMed ID: 3349209)
1. Stereoselectivity of the 4-hydroxylation of debrisoquine in man, detected by gas chromatography/mass spectrometry.
Meese CO; Fischer C; Eichelbaum M
Biomed Environ Mass Spectrom; 1988 Jan; 15(2):63-6. PubMed ID: 3349209
[TBL] [Abstract][Full Text] [Related]
2. Characterization of stereoselectivity and genetic polymorphism of the debrisoquine hydroxylation in man via analysis of urinary debrisoquine and 4-hydroxydebrisoquine by capillary electrophoresis.
Lanz M; Theurillat R; Thormann W
Electrophoresis; 1997 Sep; 18(10):1875-81. PubMed ID: 9372283
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of debrisoquine sulfate. Identification of some urinary metabolites in rat and man.
Allen JG; East PB; Francis RJ; Haigh JL
Drug Metab Dispos; 1975; 3(5):332-7. PubMed ID: 241613
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.
Zhen Y; Slanar O; Krausz KW; Chen C; Slavík J; McPhail KL; Zabriskie TM; Perlík F; Gonzalez FJ; Idle JR
Drug Metab Dispos; 2006 Sep; 34(9):1563-74. PubMed ID: 16782768
[TBL] [Abstract][Full Text] [Related]
5. Direct determination of debrisoquine and 4-hydroxydebrisoquine using a high-performance liquid chromatographic switching technique.
Decolin D; Nicolas A; Motassim N; Siest G
J Chromatogr; 1987 Aug; 419():469-74. PubMed ID: 3667807
[No Abstract] [Full Text] [Related]
6. Assay of debrisoquine and 4-hydroxydebrisoquine in urine by reversed-phase high-performance liquid chromatography using on-line sample clean-up on a standard isocratic chromatograph.
Moncrieff J
J Chromatogr; 1988 Jun; 428(1):178-82. PubMed ID: 3170673
[No Abstract] [Full Text] [Related]
7. Polymorphic hydroxylation of Debrisoquine in man.
Mahgoub A; Idle JR; Dring LG; Lancaster R; Smith RL
Lancet; 1977 Sep; 2(8038):584-6. PubMed ID: 71400
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gas chromatographic and high-performance liquid chromatographic assays for the determination of debrisoquine and its 4-hydroxy metabolite in human fluids.
Chan K
J Chromatogr; 1988 Mar; 425(2):311-21. PubMed ID: 3372645
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic method for the analysis of debrisoquine and its S-(+)- and R-(-)-hydroxy metabolites in urine.
Meese CO; Thalheimer P; Eichelbaum M
J Chromatogr; 1987 Dec; 423():344-50. PubMed ID: 3443671
[No Abstract] [Full Text] [Related]
10. Hydroxylation of debrisoquine using perfused liver isolated from Sprague Dawley and DA rats: comparison with in-vivo results.
Vincent-Viry M; Deshayes S; Mothe O; Siest G; Galteau MM
J Pharm Pharmacol; 1988 Oct; 40(10):695-700. PubMed ID: 2907535
[TBL] [Abstract][Full Text] [Related]
11. The effect of urine pH on debrisoquine phenotyping: application of an HPLC-method.
Kallio J
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):223-6. PubMed ID: 2163994
[TBL] [Abstract][Full Text] [Related]
12. The metabolism of [14C]-debrisoquine in man.
Idle JR; Mahgoub A; Angelo MM; Dring LG; Lancaster R; Smith RL
Br J Clin Pharmacol; 1979 Mar; 7(3):257-66. PubMed ID: 371651
[TBL] [Abstract][Full Text] [Related]
13. Enantiospecific quantification of hexobarbital and its metabolites in biological fluids by gas chromatography/electron capture negative ion chemical ionization mass spectrometry.
Prakash C; Adedoyin A; Wilkinson GR; Blair IA
Biol Mass Spectrom; 1991 Sep; 20(9):559-64. PubMed ID: 1782205
[TBL] [Abstract][Full Text] [Related]
14. Determination of debrisoquine and metabolites in human urine by gas chromatography-mass spectrometry.
Daumas L; Sabot JF; Vermeulen E; Clapot P; Allegre F; Pinatel H; Boucherat M; Francois B
J Chromatogr; 1991 Sep; 570(1):89-97. PubMed ID: 1797839
[TBL] [Abstract][Full Text] [Related]
15. Rapid liquid chromatographic determination of debrisoquine and its hydroxy metabolite in human urine to define hydroxylation phenotypes.
Duche JC; Barre J; Tillement JP
J Chromatogr; 1987 Dec; 423():340-3. PubMed ID: 3443670
[No Abstract] [Full Text] [Related]
16. Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism.
Alván G; Grind M; Graffner C; Sjöqvist F
Clin Pharmacol Ther; 1984 Oct; 36(4):515-9. PubMed ID: 6478737
[TBL] [Abstract][Full Text] [Related]
17. Identification and quantification of arsenocholine and acetylarsenocholine in trace amounts in biological material by use of pyrolysis gas chromatography/mass spectrometry.
Norin H; Christakopoulos A; Rondahl L; Hagman A; Jacobsson S
Biomed Environ Mass Spectrom; 1987 Mar; 14(3):117-25. PubMed ID: 2953397
[TBL] [Abstract][Full Text] [Related]
18. Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine.
Eichelbaum M; Bertilsson L; Küpfer A; Steiner E; Meese CO
Br J Clin Pharmacol; 1988 Apr; 25(4):505-8. PubMed ID: 3382592
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatographic assay for debrisoquine and 4-hydroxydebrisoquine in urine.
Westwood BE; Harman PJ; Mashford ML
J Chromatogr; 1986 Jan; 374(1):200-3. PubMed ID: 3949930
[No Abstract] [Full Text] [Related]
20. Metabolism of N-hydroxyguanidines (N-hydroxydebrisoquine) in human and porcine hepatocytes: reduction and formation of glucuronides.
Froehlich AK; Girreser U; Clement B
Drug Metab Dispos; 2005 Oct; 33(10):1532-7. PubMed ID: 16033947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
